Elanco Animal Health (NASDAQ:ELAN) Releases FY19 Earnings Guidance

Share on StockTwits

Elanco Animal Health (NASDAQ:ELAN) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.04-1.10 for the period, compared to the Thomson Reuters consensus estimate of $1.09. The company issued revenue guidance of $3.08-3.12 billion, compared to the consensus revenue estimate of $3.11 billion.

ELAN stock opened at $29.85 on Wednesday. Elanco Animal Health has a twelve month low of $28.00 and a twelve month high of $37.61. The business’s fifty day moving average price is $33.09.

Elanco Animal Health (NASDAQ:ELAN) last released its earnings results on Tuesday, August 13th. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.02. The firm had revenue of $781.60 million for the quarter, compared to the consensus estimate of $781.49 million. The business’s quarterly revenue was up 1.5% compared to the same quarter last year.

A number of research firms recently commented on ELAN. BMO Capital Markets upped their price objective on Elanco Animal Health from $32.00 to $35.00 and gave the company a market perform rating in a report on Friday, May 10th. Zacks Investment Research downgraded Elanco Animal Health from a buy rating to a hold rating in a report on Wednesday, July 10th. Finally, Guggenheim began coverage on Elanco Animal Health in a report on Wednesday, May 22nd. They issued a neutral rating for the company. One research analyst has rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of Hold and an average target price of $33.56.

Elanco Animal Health Company Profile

There is no company description available for Elanco Animal Health Inc

Featured Article: How accurate is the Rule of 72?

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Schwab U.S. REIT ETF  is DiMeo Schneider & Associates L.L.C.’s 10th Largest Position
Schwab U.S. REIT ETF is DiMeo Schneider & Associates L.L.C.’s 10th Largest Position
Orthofix Medical Inc  Shares Acquired by Oakview Capital Management L.P.
Orthofix Medical Inc Shares Acquired by Oakview Capital Management L.P.
General Motors  Holdings Decreased by Oakview Capital Management L.P.
General Motors Holdings Decreased by Oakview Capital Management L.P.
Vanguard S&P 500 ETF  Shares Sold by DiMeo Schneider & Associates L.L.C.
Vanguard S&P 500 ETF Shares Sold by DiMeo Schneider & Associates L.L.C.
Oakview Capital Management L.P. Lowers Stock Holdings in NetApp Inc.
Oakview Capital Management L.P. Lowers Stock Holdings in NetApp Inc.
Oakview Capital Management L.P. Takes $23.06 Million Position in Corteva
Oakview Capital Management L.P. Takes $23.06 Million Position in Corteva


© 2006-2019 Ticker Report